Web-based intensive monitoring of adverse events following influenza vaccination in general practice.

[1]  L. Härmark,et al.  Non‐response in a pharmacy and patient‐based intensive monitoring system: a quantitative study on non‐response bias and reasons for non‐response , 2012, The International journal of pharmacy practice.

[2]  Rumke Hc,et al.  Reported adverse events following influenza vaccination , 2014 .

[3]  M. Watson,et al.  Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting , 2012, Drug Safety.

[4]  L. Härmark,et al.  Web-based intensive monitoring: from passive to active drug surveillance , 2012, Expert opinion on drug safety.

[5]  E. Hak,et al.  Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring. , 2011, Vaccine.

[6]  I. Cook.  Sex differences in injection site reactions with human vaccines , 2009, Human vaccines.

[7]  T. Egberts.  Signal Detection , 2007, Drug safety.

[8]  D. Burwen,et al.  Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Robert T. Chen,et al.  The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). , 2002, Vaccine.

[10]  D. Scheifele,et al.  Evaluation of adverse events after influenza vaccination in hospital personnel. , 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.